BioCentury | Aug 6, 2012
Company News

Medical Research Council pharmaceuticals news

...while each company received up to £150,000 ($235,710). Companies receiving funding include infectious disease company Absynth Biologics Ltd....
BioCentury | Aug 1, 2012
Politics & Policy

U.K. biomedical fund announces first awards

...while each company received up to L150,000 ($235,710). Companies receiving funding include infectious disease company Absynth Biologics Ltd....
BioCentury | Sep 6, 2010
Finance

Regulatory milestones

...cash (see B2). MorphoSys AG (Xetra:MOR) lost €0.05 to €16.45 last week after partnering with Absynth Biologics Ltd....
BioCentury | Sep 6, 2010
Company News

Absynth Biologics, MorphoSys deal

...an upfront payment and is eligible for milestones and royalties. Further details were not disclosed. Absynth Biologics Ltd....
BioCentury | Sep 3, 2010
Company News

MorphoSys, Absynth in infectious deal

...MorphoSys AG (Xetra:MOR) partnered with Absynth Biologics Ltd. (Sheffield, U.K.) to discover and develop antibodies against Absynth's targets...
BioCentury | Feb 5, 2007
Company News

Biofusion plc, University of Sheffield deal

...The university spun out Absynth Biologics Ltd. (Sheffield, U.K.), which will use the university’s antibody-recognition technology to develop...
Items per page:
1 - 6 of 6
BioCentury | Aug 6, 2012
Company News

Medical Research Council pharmaceuticals news

...while each company received up to £150,000 ($235,710). Companies receiving funding include infectious disease company Absynth Biologics Ltd....
BioCentury | Aug 1, 2012
Politics & Policy

U.K. biomedical fund announces first awards

...while each company received up to L150,000 ($235,710). Companies receiving funding include infectious disease company Absynth Biologics Ltd....
BioCentury | Sep 6, 2010
Finance

Regulatory milestones

...cash (see B2). MorphoSys AG (Xetra:MOR) lost €0.05 to €16.45 last week after partnering with Absynth Biologics Ltd....
BioCentury | Sep 6, 2010
Company News

Absynth Biologics, MorphoSys deal

...an upfront payment and is eligible for milestones and royalties. Further details were not disclosed. Absynth Biologics Ltd....
BioCentury | Sep 3, 2010
Company News

MorphoSys, Absynth in infectious deal

...MorphoSys AG (Xetra:MOR) partnered with Absynth Biologics Ltd. (Sheffield, U.K.) to discover and develop antibodies against Absynth's targets...
BioCentury | Feb 5, 2007
Company News

Biofusion plc, University of Sheffield deal

...The university spun out Absynth Biologics Ltd. (Sheffield, U.K.), which will use the university’s antibody-recognition technology to develop...
Items per page:
1 - 6 of 6